Literature DB >> 26264620

Reply to: "in vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis".

Li Xu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26264620     DOI： 10.1007/s13277-015-3895-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  6 in total

1.  Re: Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.

Authors:  B Battal; Y Bozkurt; S Hamcan; V Akgun
Journal:  Clin Radiol       Date:  2013-10-23       Impact factor: 2.350

2.  Comments on "In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis".

Authors:  Zhenyin Liu; Jing Zhang
Journal:  Tumour Biol       Date:  2015-05-22

3.  In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis.

Authors:  Jieying Tan; Li Xu; Wenqing Yao; Yun Wan; Shuqin Zhou; Sherman Xuegang Xin
Journal:  Tumour Biol       Date:  2014-09-27

4.  Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration.

Authors:  Bonnie N Joe; Victoria Y Chen; Nouha Salibi; Pornpim Fuangtharntip; Charles F Hildebolt; Kyongtae T Bae
Journal:  Invest Radiol       Date:  2005-07       Impact factor: 6.016

Review 5.  Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T--systematic review and meta-analysis.

Authors:  Pascal A T Baltzer; Matthias Dietzel
Journal:  Radiology       Date:  2013-03-06       Impact factor: 11.105

6.  Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.

Authors:  E Kousi; I Tsougos; K Vasiou; K Theodorou; A Poultsidi; I Fezoulidis; C Kappas
Journal:  ScientificWorldJournal       Date:  2012-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.